Naloxone

Product Details

Naloxone is for complete or partial reversal of CNS and especially respiratory depression, caused by natural or synthetic opioids.

Orpha-Devel Handels und Vertriebs GmbH is the MA-Holder and AOP Health has the distribution rights.

400 microgram/ml solution for injection or infusion

Please use the emc links below to download PIL:

https://www.medicines.org.uk/emc/files/pil.8967.pdf